Bioxcel Therapeutics Stock Market Value
| BTAI Stock | USD 0.47 0.04 7.84% |
| Symbol | BioXcel |
BioXcel Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioXcel Therapeutics. If investors know BioXcel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioXcel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.04) | Revenue Per Share 0.074 | Quarterly Revenue Growth 1.416 | Return On Assets (0.64) | Return On Equity (17.67) |
The market value of BioXcel Therapeutics is measured differently than its book value, which is the value of BioXcel that is recorded on the company's balance sheet. Investors also form their own opinion of BioXcel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is BioXcel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioXcel Therapeutics' market value can be influenced by many factors that don't directly affect BioXcel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioXcel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioXcel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioXcel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BioXcel Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioXcel Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioXcel Therapeutics.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in BioXcel Therapeutics on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding BioXcel Therapeutics or generate 0.0% return on investment in BioXcel Therapeutics over 30 days. BioXcel Therapeutics is related to or competes with Terns Pharmaceuticals, Amylyx Pharmaceuticals, Acumen Pharmaceuticals, Inozyme Pharma, X4 Pharmaceuticals, Day One, and Apellis Pharmaceuticals. BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches ... More
BioXcel Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioXcel Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioXcel Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 39.77 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 9.62 |
BioXcel Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioXcel Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioXcel Therapeutics' standard deviation. In reality, there are many statistical measures that can use BioXcel Therapeutics historical prices to predict the future BioXcel Therapeutics' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.47) | |||
| Total Risk Alpha | (1.17) | |||
| Treynor Ratio | (0.08) |
BioXcel Therapeutics Backtested Returns
BioXcel Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0318, which signifies that the company had a -0.0318% return per unit of risk over the last 3 months. BioXcel Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioXcel Therapeutics' Mean Deviation of 4.54, standard deviation of 6.23, and Risk Adjusted Performance of (0.01) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.35, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, BioXcel Therapeutics will likely underperform. At this point, BioXcel Therapeutics has a negative expected return of -0.2%. Please make sure to confirm BioXcel Therapeutics' maximum drawdown, daily balance of power, relative strength index, as well as the relationship between the skewness and day typical price , to decide if BioXcel Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.02 |
Very weak reverse predictability
BioXcel Therapeutics has very weak reverse predictability. Overlapping area represents the amount of predictability between BioXcel Therapeutics time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioXcel Therapeutics price movement. The serial correlation of -0.02 indicates that only 2.0% of current BioXcel Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.02 | |
| Spearman Rank Test | -0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
BioXcel Therapeutics lagged returns against current returns
Autocorrelation, which is BioXcel Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioXcel Therapeutics' stock expected returns. We can calculate the autocorrelation of BioXcel Therapeutics returns to help us make a trade decision. For example, suppose you find that BioXcel Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BioXcel Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioXcel Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioXcel Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioXcel Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
BioXcel Therapeutics Lagged Returns
When evaluating BioXcel Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioXcel Therapeutics stock have on its future price. BioXcel Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioXcel Therapeutics autocorrelation shows the relationship between BioXcel Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in BioXcel Therapeutics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether BioXcel Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioXcel Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioxcel Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioxcel Therapeutics Stock:Check out BioXcel Therapeutics Correlation, BioXcel Therapeutics Volatility and BioXcel Therapeutics Alpha and Beta module to complement your research on BioXcel Therapeutics. For more detail on how to invest in BioXcel Stock please use our How to Invest in BioXcel Therapeutics guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
BioXcel Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.